ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Puerto Rico » Rheumatology

Top Rheumatology Prescribers in Puerto Rico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DENNIS SUAREZ MD

Rheumatology

23,390

$1.75M

1701
984 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $105

ROBERTO ALVAREZ M.D.

Rheumatology

19,820

$1.6M

1268
578 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $105

MICHAEL BABILONIA ROMAN M.D.

Rheumatology

14,026

$1.77M

1251
645 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $105

JORGE MUNDO MD

Rheumatology

13,284

$1.76M

1839
950 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $105

NOEMI VARELA-ROSARIO MD

Rheumatology

11,956

$1.2M

765
485 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $105

CARLOS PANTOJAS M.D.

Rheumatology

11,847

$636K

1090
762 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $105

ROBERTO RIVERA RIVERA M.D.

Rheumatology

11,676

$776K

839
484 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $105

ANTONIO MORALES-LOPEZ M.D.

Rheumatology

7,643

$567K

725
433 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $105

EFRAIN CARRASQUILLO M.D.

Rheumatology

7,387

$750K

1049
646 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $105

RAMON TORO TORRES MD

Rheumatology

7,124

$471K

691
455 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $105

YOLANDA LOPEZ-LOPEZ M.D.

Rheumatology

7,072

$740K

774
578 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $105

MARILU COLON M.D.

Rheumatology

6,882

$549K

661
382 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $105

FREDERICK FONT MD

Rheumatology

6,856

$450K

807
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $105

EDRICK LOPEZ-ENRIQUEZ MD

Rheumatology

6,106

$519K

1005
744 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $105

ANA MARTINEZ M.D.

Rheumatology

6,036

$546K

643
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $105

LIVIA BERMUDEZ M.D.

Rheumatology

5,929

$1.38M

739
474 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$233
Average prescription price

Avg: $105

JOSE IRIZARRY MD

Rheumatology

5,870

$420K

968
324 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

1%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$72
Average prescription price

Avg: $105

WILLIAM MATOS-SANTIAGO M.D.

Rheumatology

5,594

$586K

488
394 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $105

LILLIAN BEZARES M.D.

Rheumatology

5,502

$738K

571
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $105

ELENA VELAZQUEZ DOCTOR RHEUMATOLOGY

Rheumatology

5,403

$473K

736
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $105

MARIA JUSTINIANO M.D.

Rheumatology

5,296

$340K

559
418 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $105

BRAULIO QUINTERO MD FACR

Rheumatology

5,248

$586K

856
673 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $105

OSVALDO ANTOMMATTEI MD

Rheumatology

4,597

$849K

526
352 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$185
Average prescription price

Avg: $105

RODOLFO CONCEPCION ROSADO M.D.

Rheumatology

4,304

$401K

453
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $105

ROBERTO LEON-PEREZ MD

Rheumatology

4,292

$806K

609
384 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$188
Average prescription price

Avg: $105

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank